SCHEMBL28654715

SCHEMBL28654715

Cc1c(Cl)cc2[nH]ncc2c1Oc1cccc2c(N3CCN(C(=O)OC(C)(C)C)CC3)c(C#N)c(Cl)nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ NR1H2 P55055 1/20 0.35
▸ NR1H3 Q13133 1/20 0.35
▸ CCNK O75909 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CCND3 P30281 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CDK6 Q00534 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ SQOR Q9Y6N5 1/20 0.34
▸ RET P07949 1/20 0.34
▸ ALK Q9UM73 2/20 0.33
▸ SUV39H2 Q9H5I1 2/20 0.33
▸ KIT P10721 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ MAPK8 P45983 1/20 0.33
▸ CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30950231 1.00 KCNH2 (0.35) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL28673619 0.94 KRAS (0.38) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL30950243 0.94 KRAS (0.38) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL30950272 0.92 KCNH2 (0.36) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL28929882 0.92 KCNH2 (0.36) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL28655570 0.90 KCNH2 (0.35) KCNH2NR1H2NR1H3CCNKCCNA2
SCHEMBL30950217 0.90 KCNH2 (0.35) KCNH2NR1H2NR1H3CCNKCCNA2
SCHEMBL30950264 0.90 KRAS (0.42) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL28669680 0.90 KRAS (0.42) KCNH2IDO1TDO2NR1H2NR1H3
SCHEMBL30950196 0.82 KCNH2 (0.36) KCNH2NR1H2NR1H3SQORRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 — — CN disclosed
CN-113637005-A KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2021-11-12 — — CN disclosed
Send feedback